The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation
Open accessAbstract
Purpose: Age has long been used as a major factor for assessing suitability for allogeneic hematopoietic cell transplantation (HCT). The HCT-comorbidity index (HCT-CI) was developed as a measure of health status to predict mortality risk after HCT. Whether age, comorbidities, or both should guide decision making for HCT is unknown. Patients and Methods: Data from 3,033 consecutive recipients of HLA-matched grafts from five institutions contributed to this analysis. Patients were randomly divided into a training set to develop weights for age intervals and a validation set to assess the performance of prognostic models. Results: In the training set, patients age 20 to 39 years, 40 to 49 years, 50 to 59 years, and ≥ 60 years had hazard ratios for nonrelapse mortality (NRM) of 1.21 (P = .29), 1.48 (P = .04), 1.75 (P = .004), and 1.84 (P = .005), respectively, compared with those age younger than 20 years. Consequently, age ≥ 40 years was assigned a weight of 1 to be added to the HCT-CI to constitute a composite comorbidity/age index. In the validation set, the composite comorbidity/age score had statistically significantly higher c-statistic estimates for prediction of NRM (0.664 v 0.556; P < .001) and survival (0.682 v 0.560; P < .001) compared with age, respectively. Patients with comorbidity/age scores of 0 to 2 had comparable mortality risks regardless of conditioning regimens. Patients with scores of 3 to 4 and ≥ 5 had statistically significant higher mortality risks after high-dose versus nonmyeloablative regimens. Conclusion: Age is a poor prognostic factor. The proposed composite measure allows integration of both comorbidities and age into clinical decision making and comparative-effectiveness research of HCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goycoolea, A. (1997) · Cited by 3,615
Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Self-citationStatistical Models Based on Counting Processes
Bry, X., Andersen, P. K., Borgan, Ø., Gill, R. D., Keiding, N., & Borgan, O. (1997) · Population (French Edition) · doi:10.2307/1534625 · Cited by 2,884
Statistical Models Based on Counting Processes
Andersen, P. K., Borgan, Ø., Gill, R. D., & Keiding, N. (1993) · Springer Series in Statistics · doi:10.1007/978-1-4612-4348-9 · Cited by 2,855
Regression modelling strategies for improved prognostic prediction
Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,798
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., & Buchholz, T. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8983 · Cited by 1,721
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544
Gratwohl, A., Hermans, J., Goldman, J., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H., Niederwieser, D., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03030-x · Cited by 646
McClune, B. L., Weisdorf, D. J., Pedersen, T. L., Tunes da Silva, G., Tallman, M. S., Sierra, J., DiPersio, J., Keating, A., Gale, R. P., George, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4821 · Cited by 487
Self-citationHLA-C–Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Venstrom, J. M., Pittari, G., Gooley, T. A., Chewning, J. H., Spellman, S., Haagenson, M., Gallagher, M. M., Malkki, M., Petersdorf, E., Dupont, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200503 · Cited by 429
de Lima, M., Couriel, D., Thall, P. F., Wang, X., Madden, T., Jones, R., Shpall, E. J., Shahjahan, M., Pierre, B., Giralt, S., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0414 · Cited by 415
Sorror, M. L., Sandmaier, B. M., Storer, B. E., Maris, M. B., Baron, F., Maloney, D. G., Scott, B. L., Deeg, H. J., Appelbaum, F. R., & Storb, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7865 · Cited by 397
Self-citationA disease risk index for patients undergoing allogeneic stem cell transplantation
Armand, P., Gibson, C. J., Cutler, C., Ho, V. T., Koreth, J., Alyea, E. P., Ritz, J., Sorror, M. L., Lee, S. J., Deeg, H. J., et al. (2012) · Blood · doi:10.1182/blood-2012-03-418202 · Cited by 384
Self-citationSorror, M. L., Sandmaier, B. M., Storer, B. E., Franke, G. N., Laport, G. G., Chauncey, T. R., Agura, E., Maziarz, R. T., Langston, A., Hari, P., et al. (2011) · JAMA · doi:10.1001/jama.2011.1558 · Cited by 320
Self-citationLim, Z., Brand, R., Martino, R., van Biezen, A., Finke, J., Bacigalupo, A., Beelen, D., Devergie, A., Alessandrino, E., Willemze, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8073 · Cited by 299
Sorror, M. L., Storer, B. E., Sandmaier, B. M., Maris, M., Shizuru, J., Maziarz, R., Agura, E., Chauncey, T. R., Pulsipher, M. A., McSweeney, P. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4757 · Cited by 279
Self-citationHealth Care Reform and Cost Control
Orszag, P. R., & Emanuel, E. J. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006571 · Cited by 248
Sorror, M. L., Logan, B. R., Zhu, X., Rizzo, J. D., Cooke, K. R., McCarthy, P. L., Ho, V. T., Horowitz, M. M., & Pasquini, M. C. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2015.04.004 · Cited by 217
Self-citationHow I assess comorbidities before hematopoietic cell transplantation
Sorror, M. L. (2013) · Blood · doi:10.1182/blood-2012-09-455063 · Cited by 217
Self-citationIndependent prognostic factors for AML outcome
Grimwade, D., & Hills, R. K. (2009) · Hematology · doi:10.1182/asheducation-2009.1.385 · Cited by 180
Kahl, C., Storer, B. E., Sandmaier, B. M., Mielcarek, M., Maris, M. B., Blume, K. G., Niederwieser, D., Chauncey, T. R., Forman, S. J., Agura, E., et al. (2007) · Blood · doi:10.1182/blood-2007-03-078592 · Cited by 163
Self-citationAdjusted survival curve estimation using covariates
Makuch, R. W. (1982) · Journal of Chronic Diseases · doi:10.1016/0021-9681(82)90058-3 · Cited by 162
Deeg, H. J., Scott, B. L., Fang, M., Shulman, H. M., Gyurkocza, B., Myerson, D., Pagel, J. M., Platzbecker, U., Ramakrishnan, A., Radich, J. P., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423046 · Cited by 160
Self-citationA perspective on the selection of unrelated donors and cord blood units for transplantation
Spellman, S. R., Eapen, M., Logan, B. R., Mueller, C. R., Rubinstein, P., Setterholm, M. I., Woolfrey, A. E., Horowitz, M. M., Confer, D. L., & Hurley, C. K. (2012) · Blood · doi:10.1182/blood-2012-03-379032 · Cited by 146
Frassoni, F., Labopin, M., Gluckman, É., Prentice, H. G., Vernant, J., Zwaan, F. E., Grañena, A., Gahrton, G., de Witte, T. J. M., Gratwohl, A. A., et al. (1996) · PubMed · Cited by 119
Majhail, N. S., Brunstein, C. G., Tomblyn, M., Thomas, A. J., Miller, J. S., Arora, M., Kaufman, D. S., Burns, L. J., Slungaard, A., McGlave, P. B., et al. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.12.488 · Cited by 117
Raimondi, R., Tosetto, A., Oneto, R., Cavazzina, R., Rodeghiero, F., Bacigalupo, A. P., Fanin, R., Rambaldi, A., & Bosi, A. (2012) · Blood · doi:10.1182/blood-2012-03-414573 · Cited by 114
Nemecek, E. R., Guthrie, K. A., Sorror, M. L., Wood, B. L., Doney, K., Hilger, R. A., Scott, B. L., Kovacsovics, T. J., Maziarz, R. T., Woolfrey, A. E., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.05.007 · Cited by 101
Self-citationMHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation
Petersdorf, E. W., Malkki, M., Gooley, T. A., Spellman, S. R., Haagenson, M. D., Horowitz, M. M., & Wang, T. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003974 · Cited by 62
Pavlů, J., Kew, A. K., Taylor-Roberts, B., Auner, H. W., Marín, D., Olavarría, E., Kanfer, E., Macdonald, D. H. C., Milojković, D., Rahemtulla, A., et al. (2010) · Blood · doi:10.1182/blood-2010-01-263624 · Cited by 58
Gómez‐Núñez, M., Martino, R., Caballero, M. D., Pérez‐Simón, J. A., Canals, C., Mateos, M., Sarrà, J., León, A., Solano, C., Moraleda, J. M., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704379 · Cited by 39
Cited by
Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., et al. (2017) · Blood · doi:10.1182/blood-2016-08-733196 · Cited by 5,775
Self-citationDöhner, H., Weisdorf, D. J., & Bloomfield, C. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1406184 · Cited by 3,306
Döhner, H., Wei, A. H., Appelbaum, F. R., Craddock, C., DiNardo, C. D., Dombret, H., Ebert, B. L., Fenaux, P., Godley, L. A., Hasserjian, R. P., et al. (2022) · Blood · doi:10.1182/blood.2022016867 · Cited by 3,279
Self-citationKhwaja, A., Bjorkholm, M., Gale, R. E., Levine, R. L., Jordan, C. T., Ehninger, G., Bloomfield, C. D., Estey, E., Burnett, A., Cornelissen, J. J., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.10 · Cited by 592
Self-citationde Witte, T., Bowen, D., Robin, M., Malcovati, L., Niederwieser, D., Yakoub-Agha, I., Mufti, G. J., Fenaux, P., Sanz, G., Martino, R., et al. (2017) · Blood · doi:10.1182/blood-2016-06-724500 · Cited by 379
Self-citation
Metadata
- Authors
- Sorror, M. L., Storb, R. F., Sandmaier, B. M., Maziarz, R. T., Pulsipher, M. A., Maris, M. B., Bhatia, S., Ostronoff, F., Deeg, H. J., Syrjala, K. L., Estey, E., Maloney, D. G., Appelbaum, F. R., Martin, P. J., & Storer, B. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-10-10
- Volume
- 32
- Issue
- 29
- Pages
- 3249-3256
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2067831127
- Cited by
- 423
- References
- 31
- FWCI
- 24.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.